Deborah M. Messemer's most recent trade in Allogene Therapeutics Inc was a trade of 13,313 Common Stock done at an average price of $2.4 . Disclosure was reported to the exchange on Feb. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 2.43 per share. | 18 Feb 2025 | 13,313 | 144,316 (0%) | 0% | 2.4 | 32,351 | Common Stock |
TPG Inc - Ordinary Shares ... | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 61.91 per share. | 14 Jan 2025 | 1,695 | 15,841 | - | 61.9 | 104,931 | Class A Common Stock |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 2.18 per share. | 09 Dec 2024 | 9,136 | 157,629 (0%) | 0% | 2.2 | 19,916 | Common Stock |
TPG Inc - Ordinary Shares ... | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 46.55 per share. | 15 Jul 2024 | 4,089 | 17,536 | - | 46.5 | 190,332 | Class A Common Stock |
TPG Inc - Ordinary Shares ... | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 3,592 | 21,625 | - | - | Class A Common Stock | |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 2.28 per share. | 18 Jun 2024 | 18,641 | 166,765 (0%) | 0% | 2.3 | 42,488 | Common Stock |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 122,950 | 185,406 (0%) | 0% | 0 | Common Stock | |
PayPal Holdings Inc | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 61.65 per share. | 24 May 2024 | 4,422 | 13,976 (0%) | 0% | 61.6 | 272,616 | Common Stock |
PayPal Holdings Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2024 | 4,422 | 18,398 (0%) | 0% | 0 | Common Stock | |
TPG Inc - Ordinary Shares ... | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 43.97 per share. | 28 Feb 2024 | 6,390 | 18,033 | - | 44.0 | 280,980 | Class A Common Stock |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 18 Dec 2023 | 18,640 | 62,456 (0%) | 0% | 2.7 | 50,317 | Common Stock |
TPG Inc - Ordinary Shares ... | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2023 | 5,111 | 24,423 | - | - | Class A Common Stock | |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 74,561 | 81,096 (0%) | 0% | 0 | Common Stock | |
PayPal Holdings Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2023 | 4,450 | 13,976 (0%) | 0% | 0 | Common Stock | |
TPG Inc - Ordinary Shares ... | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2022 | 9,142 | 19,312 | - | - | Restricted Stock Units | |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 71,070 | 71,070 | - | - | Stock Option (Right to Buy) | |
PayPal Holdings Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2022 | 3,114 | 9,526 (0%) | 0% | 0 | Common Stock | |
TPG Inc - Ordinary Shares ... | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2022 | 10,170 | 10,170 | - | - | Restricted Stock Units | |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 28,015 | 28,015 | - | - | Stock Option (Right to Buy) | |
PayPal Holdings Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2021 | 1,053 | 6,412 (0%) | 0% | 0 | Common Stock | |
Allogene Therapeutics Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2020 | 16,640 | 16,640 | - | - | Stock Option (Right to Buy) | |
PayPal Holdings Inc | Deborah M. Messemer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2020 | 1,856 | 5,359 (0%) | 0% | 0 | Common Stock |